Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 1 1

Status

Suspended 1Recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Thoracic 2

Conditions

Prostatic Neoplasms 2Lung Neoplasms 2Odontogenic Cysts 1Nose Neoplasms 1Neoplasms 1Melanoma 1Liver Neoplasms 1Kidney Neoplasms 1Esthesioneuroblastoma, Olfactory 1Cholangiocarcinoma 1Carcinoma, Hepatocellular 1Cancer Diagnosis 1

Interventions

Carboplatin 340Cisplatin 238Paclitaxel 203Radiotherapy 195Pemetrexed 187Docetaxel 169Gemcitabine 157pembrolizumab 141Erlotinib Hydrochloride 107Etoposide 99Magnetic Resonance Spectroscopy 93Bevacizumab 91Specimen Handling 76Nivolumab 73Radiosurgery 72durvalumab 69Vinorelbine 54osimertinib 53Gefitinib 49Drug Therapy 49atezolizumab 42Irinotecan 42Radiation 40Topotecan 39Biopsy 39Standard of Care 38Cyclophosphamide 38Cetuximab 35Blood Specimen Collection 33Taxes 32

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Lung Neoplasms × Radionuclide Imaging × Clear all
NCT04017819 2025-11-05

Biodistribution&Pharmacokinetic of Position Emission Tomography(PET) Radiopharmaceutical 18F C SNAT4

Stanford University

Phase 1 Suspended
20 enrolled
Thoracic

Lung Neoplasms, Neoplasms

NCT06626178 2024-10-03

ARIA

Scientific Institute San Raffaele

Phase NA Recruiting
2,840 enrolled
Thoracic

Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡